New medicines that mimic a natural gut hormone called GLP-1 have already changed how clinicians treat type 2 diabetes, obesity and related cardiometabolic consequences
10.1186/s13023-017-0706-1 Orphanet J Rare Dis
Sudden disruptions and gradual, undesirable changes are frequently addressed in similar ways, which can create ambiguities in planning and response strategies
Beneficial effects of pentadecapeptide BPC 157 on traumatic brain injuries
Pulse GH secretion tends to increase GH mRNA and pituitary GH stores, generating a more physiologic, pulsatile release
This reflects the massmarket scale of obesity and diabetes, where oral options could materially expand access, persistence, and earlier therapy initiation or continuation of treatment for patients moving from injectable to orals, Campbell said